Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies

Neurology

Volumn 66, Issue 10, 2006, Pages 1591-1593

  Zaja Milatovic, S ^a   Keene, C D ^a   Montine, K S ^a   Leverenz, J B ^a   Tsuang, D ^a   Montine, T J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DEMENTIA WITH LEWY BODY; DENDRITE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MEDIUM SPINY NERVE CELL; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE CELL; NERVE CELL DEGENERATION; PRIORITY JOURNAL; UNITED STATES; ALZHEIMER DISEASE; CLASSIFICATION; DIFFUSE LEWY BODY DISEASE; MENTAL FUNCTION; NERVE DEGENERATION; PATHOLOGY; PSYCHOLOGICAL ASPECT; ULTRASTRUCTURE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAUDATE NUCLEUS; DENDRITES; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MENTAL PROCESSES; NERVE DEGENERATION; NEURONS;

EID: 33745336338     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000216137.09685.c1     Document Type: Article

References (10)

1. Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996;31:166-175.
2. Kraybill ML, Larson EB, Tsuang DW, et al. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 2005;64:2069-2073.
3. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002;53:647-654.
4. Royall DR, Lauterbach EC, Cummings JL, et al. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002;14:377-405.
5. Goldman PS, Rosvold HE. The effects of selective caudate lesions in infant and juvenile Rhesus monkeys. Brain Res 1972;43:53-66.
6. Zaja-Milatovic S, Milatovic D, Schantz AM, et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005;64:545-547.
7. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002;977:9-23.
8. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
9. McKeith I, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
10. Sidell KR, Olson SJ, Ou JJ, Zhang Y, Amarnath V, Montine TJ. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. J Neurochem 2001;79:510-521.